Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP

Will Malaysia dropping AstraZeneca from main inoculation drive fuel vaccine hesitancy?

  • Only China’s Sinovac Biotech vaccine and Pfizer-BioNTech shot now offered at government vaccination centres, but AstraZeneca jab is still available as an opt-in
  • Experts say this allays public concerns over side-effects like blood clots; others say it may damage trust in vaccines and undermine global vaccination efforts

Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
READ FULL ARTICLE